iQure Pharma Inc.
through Sep 21, 2026
Offering amounts describe securities offered; amounts sold are issuer-reported as of each filing. Amendments can repeat earlier amounts. We do not add these figures into a capital-raised total. Missing amounts are not zero. Data coverage and methodology · How to interpret the amounts.
Differences between reported disclosures
Same issuer CIK; offering identity has not been established. Differences are arithmetic comparisons between disclosures, not additional capital raised, new investors or confirmed amendments to the same offering.
| Field | Jun 3, 2026 · D | Sep 21, 2026 · D/A | Later minus earlier |
|---|---|---|---|
| Reported offering amount | $4,000,000 | $4,000,000 | $0 |
| Reported amount sold | $650,000 | $2,788,315 | $2,138,315 |
| Reported investor count | 1 | 18 | 17 |
| Reported minimum investment | $0 | $0 | $0 |
Earlier SEC source: 0001996977-26-000001 · Later SEC source: 0001996977-26-000002
Choose filings to compare · Research this issuer step by step
Latest available filing snapshot
- Reported offering amount
- $4,000,000
- Reported amount sold
- $2,788,315
This is one filing's disclosure, not the issuer's lifetime fundraising or current offering status.
Filings by year
- 20252 filings
- 20262 filings
Submission counts, including amendments; not dollars raised or distinct funding rounds.
Contact info
Log in to look up an email or website for this issuer.
Form D filings (4)
-
0001996977-26-000002D/A · Sep 21, 2026 · OtherOffering: $4,000,000Sold: $2,788,315
-
0001996977-26-000001D · Jun 3, 2026 · OtherOffering: $4,000,000Sold: $650,000
-
0001996977-25-000003D · Nov 3, 2025 · OtherOffering: $1,750,000Sold: $1,503,320
-
0001996977-25-000001D · Jan 16, 2025 · OtherOffering: $1,443,786Sold: $1,443,786